Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Nov 27, 2025
- Closes
- Sep 25, 2028 (in 789 days)
Classification and identifiers
- Solicitation number
- PAR-25-444
- Assistance listing (CFDA)
- 93.397
Amount
Amount not published by the funder
Who can apply
Nonprofits, including small and volunteer-run organizations and Small businesses can all apply here. Check the eligibility details below to see if your organization fits.
Specific to this NOFO:For New (Type 1) applications, an applicant institution must have a funding base of $10,000,000 (Clinical Cancer Centers) or $6,000,000 (Basic Cancer Centers) in annual direct costs of NIH funding that is cancer-focused, as defined by the Research Condition and Disease Categorization (RCDC) system. Please contact the NCI Office of Cancer Centers (https://cancercenters.cancer.gov/) for assistance in determining the RCDC funding base.For Renewal (Type 2) applications, an applicant institution must have a funding base of at least $10,000,000 in annual direct costs of peer-reviewed, cancer-related funding. If the Cancer Center is an approved consortium of institutions, the funding base of the Center will be the sum of the funding bases of all participating institutions. H...
About this opportunity
This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three types of Cancer Centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas: basic laboratory; clinical; and prevention, control and population-based research, and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Clinical Cancer Centers, which are primarily focused on basic laboratory; clinical; and prevention, cancer control, and population-based research; or some combination of these areas, and 3) Basic Cancer Centers, which focus on basic laboratory research. The purpose of all types of NCI-Desig...
Related opportunities
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)National Institutes of HealthCloses Jan 2027
- Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)National Institutes of HealthCloses Sep 2028
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)National Institutes of HealthCloses Oct 2027
- Diabetes Research Centers (P30 Clinical Trial Optional)National Institutes of HealthCloses Jan 2027Up to $1M
- Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027Up to $500K
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)National Institutes of HealthCloses in 77 days